Abstract
Our previous data showed that the treatment of canine visceral leishmaniasis (CVL) with the recombinant cysteine proteinase from Leishmania (Leishmania) infantum chagasi, rLdccys1, plus Propionibacterium acnes as adjuvant resulted in immune protective responses and significant reduction of parasite load, control of disease development and increase of survival in treated dogs. Actually all…